Medical Marijuana Market to Experience Blatant Growth at 35.4% of CAGR during the Forecast Period 2019-2023

According to Market Research Future, the Global Medical Marijuana Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global Medical Marijuana Market and present statistics to derive.

Pune, India - February 12, 2019 /MarketersMedia/ —

Medical Marijuana Market - Synopsis

Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Some Points From TOC of Medical Marijuana Market Research Report – Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Source URL: https://marketersmedia.com/medical-marijuana-market-to-experience-blatant-growth-at-354-of-cagr-during-the-forecast-period-2019-2023/481621

Source: MarketersMedia

Release ID: 481621

Latest News

Financial questions hound 2 of F1's 3 races in North America

Feb 21, 2019

AUSTIN, Texas — Two of Formula One's three races in North America are facing financial issues that are raising concern about their future. Organizers of the U.S. Grand Prix won't be reimbursed at least $20 million from the state of Texas for the 2018 race after missing a paperwork deadline set by law. And new questions lurk about the future of the Mexican Grand Prix after the country's new president suggested the government may not spend on the race like it has the last four years. Both races have been popular with drivers and fans, and enjoy key dates on...

Sane stuns old club Schalke as City wins 3-2 in CL last 16

Feb 21, 2019

GELSENKIRCHEN, Germany — Mobbed by his Manchester City teammates after scoring a sublime free kick, Leroy Sane held out his left hand in apology to the Schalke fans who once adored him but were now stunned into silence. Sane's 85th-minute goal against his former club gave the English champions an equalizer just when it looked like they had run out of ideas in the Champions League on Wednesday. And there was worse to come for the German team. Raheem Sterling latched onto a pinpoint long ball forward from goalkeeper Ederson Moraes and calmly finished into the bottom corner in the...

Padres buzzing over impending arrival of Manny Machado

Feb 21, 2019

PEORIA, Ariz. — As workouts began to wind down, word began spreading across the San Diego Padres' practice fields at Peoria Sports Complex. The Padres, a team stuck in a 12-year playoff-less rut, were on the verge of making their biggest free agent splash ever. Manny Machado, the big-hitting, slick-fielding infielder, was going to be paid $300 million to play for the Padres for the next decade. The news Tuesday put noticeable pep in the players' step for the remainder of the workouts. "There was definitely a buzz yesterday in the practice," first baseman Eric Hosmer said Wednesday. "Toward the...

Flyers' Gudas suspended 2 games for high-sticking Kucherov

Feb 21, 2019

NEW YORK — Philadelphia Flyers defenseman Radko Gudas has been suspended two games by the NHL for high-sticking Tampa Bay Lightning forward Nikita Kucherov on Tuesday night. The play occurred late in the third period of the Lightning's 5-2 win. Gudas received a minor penalty on the play. He is considered a repeat offender under the terms of the collective bargaining agreement and will forfeit $81,707.32. Also, Flyers defenseman Robert Hagg has been fined $3,091.40, the maximum allowable under the CBA, for interference against Lightning forward Cedric Paquette early in the third period. ___ More AP NHL: https://apnews.com/NHL and https://twitter.com/AP_Sports

'Excessive fines' ban applies to states, Supreme Court says

Feb 21, 2019

WASHINGTON — Tyson Timbs admitted he'd sold drugs, and he accepted his sentence without a fight. What he wouldn't quietly accept was the police seizing and keeping the $40,000 Land Rover he'd had when arrested. On Wednesday, the Supreme Court sided with him unanimously in ruling the Constitution's ban on excessive fines applies to the states as well as the federal government. The decision, in an opinion written by Justice Ruth Bader Ginsburg, could help efforts to rein in police seizures of property from criminal suspects. Reading a summary of her opinion in the courtroom, Ginsburg noted that governments employ...

Get your 24-hour live updates here in Ultimate Sports Daily. We deliver content from all regions so that you won’t miss out on any single event.

Contact us: sales[at]ultimatesportsdaily.com